Kidney cancer: Identification of novel targets for therapy

Robert H Weiss, P. Y. Lin

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Kidney cancer, although relatively rare when compared to other malignancies, occurs not uncommonly in patients with renal disease and is often discovered incidentally during the initial nephrologic work-up, or by the savvy clinician who is familiar with the paraneoplastic signs. While surgical approaches are generally curative when the disease is confined to the kidney, one-third of the cases that present in the metastatic form and require conventional medical therapy are associated with a truly dismal patient survival rate. In light of the emerging knowledge of the molecular mechanisms of kidney cancer oncogenesis, several novel and promising therapeutic approaches are emerging. In this review, we summarize the current state of kidney cancer diagnosis and therapy, as well as some of the novel treatments that capitalize on those newly elucidated molecular pathways that are deranged in this disease.

Original languageEnglish (US)
Pages (from-to)224-232
Number of pages9
JournalKidney International
Volume69
Issue number2
DOIs
StatePublished - Jan 2006

Fingerprint

Kidney Neoplasms
Kidney
Therapeutics
Carcinogenesis
Survival Rate
Neoplasms

Keywords

  • Kidney cancer
  • Molecular targets
  • Therapy

ASJC Scopus subject areas

  • Nephrology

Cite this

Kidney cancer : Identification of novel targets for therapy. / Weiss, Robert H; Lin, P. Y.

In: Kidney International, Vol. 69, No. 2, 01.2006, p. 224-232.

Research output: Contribution to journalArticle

@article{198a2b500abc49f78ec60c3fcc7bbce8,
title = "Kidney cancer: Identification of novel targets for therapy",
abstract = "Kidney cancer, although relatively rare when compared to other malignancies, occurs not uncommonly in patients with renal disease and is often discovered incidentally during the initial nephrologic work-up, or by the savvy clinician who is familiar with the paraneoplastic signs. While surgical approaches are generally curative when the disease is confined to the kidney, one-third of the cases that present in the metastatic form and require conventional medical therapy are associated with a truly dismal patient survival rate. In light of the emerging knowledge of the molecular mechanisms of kidney cancer oncogenesis, several novel and promising therapeutic approaches are emerging. In this review, we summarize the current state of kidney cancer diagnosis and therapy, as well as some of the novel treatments that capitalize on those newly elucidated molecular pathways that are deranged in this disease.",
keywords = "Kidney cancer, Molecular targets, Therapy",
author = "Weiss, {Robert H} and Lin, {P. Y.}",
year = "2006",
month = "1",
doi = "10.1038/sj.ki.5000065",
language = "English (US)",
volume = "69",
pages = "224--232",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Kidney cancer

T2 - Identification of novel targets for therapy

AU - Weiss, Robert H

AU - Lin, P. Y.

PY - 2006/1

Y1 - 2006/1

N2 - Kidney cancer, although relatively rare when compared to other malignancies, occurs not uncommonly in patients with renal disease and is often discovered incidentally during the initial nephrologic work-up, or by the savvy clinician who is familiar with the paraneoplastic signs. While surgical approaches are generally curative when the disease is confined to the kidney, one-third of the cases that present in the metastatic form and require conventional medical therapy are associated with a truly dismal patient survival rate. In light of the emerging knowledge of the molecular mechanisms of kidney cancer oncogenesis, several novel and promising therapeutic approaches are emerging. In this review, we summarize the current state of kidney cancer diagnosis and therapy, as well as some of the novel treatments that capitalize on those newly elucidated molecular pathways that are deranged in this disease.

AB - Kidney cancer, although relatively rare when compared to other malignancies, occurs not uncommonly in patients with renal disease and is often discovered incidentally during the initial nephrologic work-up, or by the savvy clinician who is familiar with the paraneoplastic signs. While surgical approaches are generally curative when the disease is confined to the kidney, one-third of the cases that present in the metastatic form and require conventional medical therapy are associated with a truly dismal patient survival rate. In light of the emerging knowledge of the molecular mechanisms of kidney cancer oncogenesis, several novel and promising therapeutic approaches are emerging. In this review, we summarize the current state of kidney cancer diagnosis and therapy, as well as some of the novel treatments that capitalize on those newly elucidated molecular pathways that are deranged in this disease.

KW - Kidney cancer

KW - Molecular targets

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33644657042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644657042&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5000065

DO - 10.1038/sj.ki.5000065

M3 - Article

C2 - 16408110

AN - SCOPUS:33644657042

VL - 69

SP - 224

EP - 232

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -